Adverse drug reaction processing in the United States and its dependence on physician reporting: Zomepirac (Zomax®) as a case in pointCorre · Annals of Emergency Medicine1988PDF550 KB
TCT Daily: ZOMAXX I—Mixed Results with Zotarolimus-Eluting StentJournal of Interventional Cardiology2007PDF19 KB
A Randomized, Controlled, Multi-center Trial Comparing the Safety and Efficacy of Zotarolimus-eluting and Paclitaxel-eluting Stents in De Novo Lesions in Coronary Arteries: Final Results of the ZoMaxx II TrialGray · International Journal of Cardiology2012PDF382 KB
A randomized, controlled, multicenter trial to evaluate the safety and efficacy of Zotarolimus‐ vs. Paclitaxel‐eluting stents in de novo occlusive lesions in coronary arteries: Five‐year results from the ZOMAXX I trialChevalier · Catheterization and Cardiovascular Interventions2013PDF1.9 MB